Category: Covid-19 Vaccine

The Biden administration is expecting the FDA to approve a new vaccine in September. The new vaccine will protect against the omicron variant. According to ABC news, the government now has the option to buy 600 million new vaccines that are targeted toward the omicron variant, with plans to deliver 171 million this fall. The Biden administration says it's moved $10 billion to cover the cost of these vaccines. The vaccine is a bivalent meaning it protects against the alpha, delta and omicron variants. KOAT health expert Dr. Barry Ramo suggests if you're eligible to get a booster now you should get it, instead of waiting for the new shot. Right now, the idea of waiting for the new vaccine may be a mistake because we don't know what the dominant viral strain will be at the time that the vaccine is released," said Dr. Ramo. Dr. Ramo said it is proven the current vaccine still prevents serious illness hospitalization, and death, even when it comes to the omicron variant which is making up about 90% of U.S. cases. The variant is in high concentration now. People are getting sick with it. They're not getting seriously ill if they've been boosted, he said. If authorized and recommended, Dr Ramo said this is good news. I think what is encouraging is the ability to change the vaccine on a dime. So the idea that we have the technology to make a new vaccine so quickly is very important, Dr. Ramo said.

The Biden administration is expecting the FDA to approve a new vaccine in September. The new vaccine will protect against the omicron variant.

According to ABC news, the government now has the option to buy 600 million new vaccines that are targeted toward the omicron variant, with plans to deliver 171 million this fall.

The Biden administration says it's moved $10 billion to cover the cost of these vaccines.

The vaccine is a bivalent meaning it protects against the alpha, delta and omicron variants.

KOAT health expert Dr. Barry Ramo suggests if you're eligible to get a booster now you should get it, instead of waiting for the new shot.

Right now, the idea of waiting for the new vaccine may be a mistake because we don't know what the dominant viral strain will be at the time that the vaccine is released," said Dr. Ramo.

Dr. Ramo said it is proven the current vaccine still prevents serious illness hospitalization, and death, even when it comes to the omicron variant which is making up about 90% of U.S. cases.

The variant is in high concentration now. People are getting sick with it. They're not getting seriously ill if they've been boosted, he said.

If authorized and recommended, Dr Ramo said this is good news.

I think what is encouraging is the ability to change the vaccine on a dime. So the idea that we have the technology to make a new vaccine so quickly is very important, Dr. Ramo said.

Read this article:

New COVID-19 vaccine expected to release in September; should people wait to get it? - KOAT New Mexico

A research team at St. Mary's Hospital has discovered that T cell, which causes autoimmune liver disease, appears after a liver biopsy on patients who received the Covid-19 vaccine.

The research, conducted by Professors Sung Pil-soo at Seoul St. Mary's Hospital and Lee Sun-kyu at Incheon St. Mary's Hospital, supports the research result by research at Germany's University Medical Center Freiburg in April that "specific CD8+ T cells induced by Covid-19 vaccination can cause liver damage, which can cause autoimmune liver disease."

The St. Mary's Hospital research is the world's first to report a hepatic overlap syndrome, in which autoimmune hepatitis and primary biliary cholangitis co-occur after Covid-19 vaccination.

According to Professor Sung, the patient was a 57-year-old woman with no history of taking drugs for underlying diseases, alcohol, or liver disease. Still, she was referred to Seoul St. Mary's Hospital for general weakness.

The patient visited the hospital two weeks after receiving the first dose of the vaccine as she felt tired and weak in general. However, an initial physical examination showed that everything was normal. However, as a result of a blood test performed at the next visit, the hospital confirmed that the patient's liver scores related to the diagnosis of liver disease were elevated.

The team tested to determine the cause and confirmed that the results of hepatitis A, B, C, and E and viral hepatitis, such as cytomegalovirus and herpes simplex virus type 1 and 2, were negative. There were no specific findings in liver ultrasound.

In contrast, the autoantibody test showed positive antinuclear antibody and anti-mitochondrial antibodies, confirming the high possibility of autoimmune liver disease, including hepatic overlap syndrome.

Therefore, the team performed a liver tissue biopsy for diagnosis and confirmed that T cells were concentrated in the portal vein, causing infiltration and necrosis of the liver tissue.

The team also observed interfacial hepatitis and non-purulent cholangitis, in which plasma cell infiltration, fragmentary necrosis, and inflammation and necrosis of the portal vein were extended to the periphery of the portal vein.

In conclusion, the research team confirmed that the patient had hepatic overlap syndrome.

Combining these findings, the team treated the patient with high-dose ursodeoxycholic acid (UDCA), and the patient recovered back to normal within two weeks.

"This study clarifies the mechanism that can cause liver damage and liver function abnormalities due to immune response after vaccination." Professor Lee said. "It is also important to identify and treat such symptoms through detailed questionnaires and examinations during patient treatment."

Professor Sung also said, "This paper is the first report on hepatic overlap syndrome after vaccination, and careful observation and confirmation of immune response and liver disease is required."

Sung added that his team would continue to study such liver diseases to help patients, Sung added.

Journal of Hepatology published the result of the research.

Go here to see the original:

St. Mary's researchers find clue to liver dysfunction after Covid-19 vaccination - KBR

Yahoo Life Videos

The Walker Odette Annable, 37, took to Instagram on Friday to share photos of herself getting ready to welcome her second child with husband and former Brothers & Sisters co-star Dave Annable. She captioned the photos, which revealed her pregnant stomach, The very hot, very pregnant Summer.

Go here to read the rest:

A Dad Made Fun Of His Son For Getting A COVID-19 Vaccine, And 16 Other Horrific Parents From 2022 - Yahoo Life

How are monkeypox cases, COVID-19 vaccines and shingles infections connected? They are not.

But if you believe claims circulating online, they are linked to a group of global elites who are using the coronavirus "as a tool to reorganize global societies and economies to their benefit at the expense of ordinary people, with the ultimate goal of a global totalitarian regime," according to the Anti-Defamation League.

Those claims are part of "The Great Reset" conspiracy theory, which PolitiFact has repeatedly debunked. Other news outlets have also dismissed the idea as unsubstantiated.

One article pushing the narrative that monkeypox is tied to this conspiracy theory appeared on The Expos, a U.K.-focused blog that has repeatedly spread misinformation about the pandemic and COVID-19 vaccine.

"Monkeypox is only circulating in countries where the Pfizer vaccine has been distributed and is being used to advance a Technocratic Great Reset," read a July 24 Expos headline.

The article claimed that the monkeypox outbreak is actually shingles cases caused by Pfizers COVID-19 vaccines.

"Were seeing the consequences of injecting millions of people with an experimental mRNA injection that causes untold damage to the immune system," the article said. "And public health authorities are now scrambling to cover up COVID-19 vaccine-induced shingles and using it as an opportunity to advance their technocratic agenda of implementing The Great Reset."

The article was flagged as part of Facebooks efforts to combat false news and misinformation on its News Feed. (Read more about our partnership with Facebook.)

Available evidence directly refutes the articles claims.

COVID-19 vaccines are safe and effective

Pfizers mRNA vaccine, marketed as Comirnaty, in August 2021 became the first COVID-19 vaccine to achieve full approval from the U.S. Food and Drug Administration. Millions of people have received the two-dose Pfizer vaccine, which is a safe and effective way to prevent COVID-19.

A nurse gives a child, aged 5, the first dose of the Pfizer vaccine on Nov. 6, 2021. This was the first time children aged 5 to 11 across the United States had the opportunity to get immunized against COVID-19. (AP)

In the seven days after vaccination, it is common to experience mild side effects including fever, chills, fatigue or headaches, according to the Centers for Disease Control and Prevention. More severe side effects including severe allergic reactions or myocarditis and pericarditis (especially for males ages 12 to 39) are rare but can happen.

Some countries reporting monkeypox cases arent using the Pfizer vaccine

Pfizer told PolitiFact it had agreements to provide its vaccine to more than 140 countries.

As of July 28, cases of monkeypox have been reported in 77 countries, including 71 countries that have not historically reported monkeypox, the CDC reported.

A map on Pfizers website shows where it has shipped vaccines, and a map on the CDCs site also shows monkeypox cases around the world.

Comparing these maps shows that the articles claim that monkeypox is "only circulating" where the Pfizer vaccine was distributed is false.

Venezuela reported one case of monkeypox as of July 28, but Pfizers map does not show any shipments of COVID-19 vaccines. Venezuela has approved the use of Russian COVID-19 vaccines Sputnik V and Sputnik Light, Cubas Abdala and Soberana COVID-19 vaccines and the Sinopharm and Sinovac vaccines from China, according to the U.S. Embassy in Venezuela.

India reported four cases of monkeypox as of July 28. Pfizer has not sent COVID-19 vaccines to India, according to its map last updated July 3.

India is currently distributing four vaccines, per the BBC: the Oxford-AstraZeneca vaccine, Corbevax, Covaxin and Sputnik V.

Also, not all the countries that received Pfizer vaccines have reported monkeypox cases. As of July 28, for example, Indonesia has not reported any monkeypox cases, but Pfizer has shipped nearly 69 million doses of the COVID-19 vaccine there.

A medical worker shows vials of the Pfizer COVID-19 vaccine during a vaccination campaign at the Patriot Candrabhaga Stadium in Bekasi on the outskirts of Jakarta, Indonesia, on Feb. 8, 2022. (AP)

Monkeypox and shingles differ in many ways

The CDC tracks adverse events reported after COVID-19 vaccinations, and has not indicated that the vaccines cause shingles.

Nearly 10,000 cases of shingles have been reported to the CDC and FDAs Vaccine Adverse Event Reporting System after doses of the Pfizer vaccine. This does not mean the vaccines caused shingles.

VAERS is an open system, meaning anyone can submit a report to the database, "regardless of seriousness, and regardless of how likely the vaccine may have been to have caused the adverse event," per the CDC. On one occasion, a doctor said hed submitted a report that a flu vaccine had turned him into the Hulk; that report was accepted and remained in the database for some time, he said.

Pfizer said it has not seen data that suggests its COVID-19 vaccine causes shingles.

Monkeypox and shingles cause skin rashes, but they look different on the body.

Shingles causes a painful rash that typically "occurs in a single stripe around either the left or the right side of the body" or on one side of the face, according to the CDC. In contrast, monkeypox causes "a rash that can look like pimples or blisters that appears on the face, inside the mouth, and on other parts of the body, like the hands, feet, chest, genitals, or anus."

This image provided by the National Institute of Allergy and Infectious Diseases shows a colorized transmission electron micrograph of monkeypox particles (red) found within an infected cell (blue). (NIAID via AP)

The diseases are also caused by different viruses: Monkeypox is caused by an orthopoxvirus; shingles is caused by reactivation of the varicella zoster virus that also causes chickenpox.

Our ruling

A blog post claimed that monkeypox "is only circulating in countries where the Pfizer vaccine has been distributed and is being used to advance a Technocratic Great Reset."

"The Great Reset" is an unsubstantiated and widely debunked conspiracy theory. Monkeypox has been reported in countries that dont have Pfizers COVID-19 vaccine. And there are countries that received Pfizers vaccine that have not yet reported monkeypox cases.

We rate this claim False.

RELATED: Shingles-monkeypox claim misleads with false flu-COVID-19 theory

RELATED: No, the COVID-19 vaccines are not weapons of mass destruction

RELATED: Federal VAERS database is a critical tool for researchers, but a breeding ground for misinformation

Visit link:

Theres no evidence the Pfizer COVID-19 vaccine is connected to the monkeypox outbreak - PolitiFact

This week, the White House held a summit on the future of Covid-19 vaccines that brought together scientists and vaccine manufacturers to discuss new vaccine technologies. Officials said that new vaccines are an urgent priority as US Covid-19 cases and hospitalizations are rising once again, vaccination rates are hitting a plateau, Covid-19 funding is running low, and the virus itself is continuing to mutate.

But in recent months, scientists have also learned that the immune cells that provide lasting protection known as memory B cells and T cells can keep the worst effects of the most recent versions of the virus at bay, even if they were trained to corral older strains of SARS-CoV-2. Vaccine researchers are expanding their focus from antibodies to these memory immune cells as the new discoveries open a path toward universal coronavirus vaccines.

Universal vaccines, however, are still a long way off possibly years drawing on approaches never used before. Thats a scientific challenge, said Anthony Fauci, chief medical adviser to the president, during the summit.

The good news is that far fewer people are dying from the disease compared to the wave of cases this past winter spurred by the omicron variant of SARS-CoV-2, the virus that causes Covid-19. The first round of Covid-19 vaccines is still holding death rates down to around 360 per day, according to the Centers for Disease Control and Prevention. Still, health officials want to do better.

While the vaccines are terrific, hundreds of Americans, thousands of people around the world are still dying every day, Ashish Jha, the White House Covid-19 response coordinator, said Tuesday. Building a new generation of vaccines will make an enormous difference to bringing this pandemic to an end.

The National Institutes of Health is already funding several research teams developing Covid-19 vaccines that elicit protection against many different versions of the virus, shield against future changes to the virus before they arise, and protect against other coronaviruses.

From there, health officials are aiming not just to develop vaccines that provide more durable protection against a wider array of threats, but also rethinking the vaccination strategy overall. With a better understanding of long-term immunity, more robust vaccines, and a comprehensive public health approach, health officials say they have a better shot at restoring normalcy.

Much of the discussion around vaccines and immunity to Covid-19 centers on antibodies, proteins produced by the immune system that attach to the virus. And indeed, they are important.

Antibodies that prevent the virus from causing an infection in the first place are called neutralizing antibodies. A high concentration of antibodies in the body that blocks SARS-CoV-2 is a key indicator of good protection against reinfection. Antibodies can also serve as a way to mark intruders so that other immune system cells can dispose of them.

But making large quantities of antibodies takes a lot of resources from the body, so their production tapers off with time after an infection or a vaccination. Another concern is that antibodies are very particular about where they attach to the virus. If the virus has a mutation at that attachment site called an epitope antibodies have a harder time recognizing the pathogen. Thats why some antibody-based treatments for Covid-19 are a lot less effective at stopping the omicron subvariants.

Fortunately, the immune system has other tools in its chest. Inside bone marrow lie stem cells that differentiate to become B cells and T cells. Together, they form the core of the adaptive immune system, which creates a tailored response to threats. After a virus invades a cell, it hijacks its machinery to make copies of itself. White blood cells known as cytotoxic T cells, a.k.a. killer T cells, can identify the wayward cell and make it self-destruct. This mechanism doesnt prevent infections, but it stops them from growing out of control.

Another type of T cell, called a helper T cell, acts as an on switch for B cells, which are the cells that manufacture antibodies. After an infection is extinguished, some T cells and B cells turn into memory cells that stick around in parts of the body, ready to rev up if a virus dares to show up again.

So far, the adaptive immune system seems to hold up pretty well. The first round of Covid-19 vaccines was targeted against the earliest versions of the virus, so plenty of vaccinated people have had breakthrough infections, especially from the newer variants. But only a tiny fraction of those immunized have fallen severely ill or have died.

That likely means that their immune systems couldnt keep the virus out entirely, but their immune cells were able to spool up once an infection took root.

Someones neutralizing antibodies may not be up to the task, but if they have the T cell response, that may make all the difference with severe disease, said Stephen Jameson, a professor of microbiology and immunology at the University of Minnesota.

In just the past year, many studies have borne out the significance of memory B cells and T cells for long-term Covid-19 immunity and answered critical questions about whether they can respond to new variants.

Researchers have found that lower levels of memory B cells were associated with a greater risk of breakthrough infections from the delta variant. On the other hand, B cells induced by Covid-19 vaccines could reactivate months out from the initial vaccine doses to churn out antibodies.

Similarly, scientists found that T cells generated by vaccines were able to recognize SARS-CoV-2 variants like omicron months later. These data provide reasons for optimism, as most vaccine-elicited T cell responses remain capable of recognizing all known SARS-CoV-2 variants, scientists wrote in a March paper in the journal Cell.

Another study showed that Covid-19 vaccines generated strong T cell memory that protected against the virus even without neutralizing antibodies. I think the immunological memory which is induced by vaccines is pretty good and is actually sustained, said Marulasiddappa Suresh, a professor of immunology at the University of Wisconsin-Madison who co-authored the study, published in the Proceedings of the National Academy of Sciences in May.

Whether this protection will hold up over the course of years remains to be seen. Experiences with past coronaviruses like MERS showed that antibodies to the virus can last for four years. Covid-19, however, is spreading at much higher levels and mutating more than MERS did during its initial outbreak. Future protection against the disease hinges on the immune system as well as how much the virus itself will change, and scientists are closely watching both.

Most vaccines to date are designed to counter one or a handful of versions of a given virus. They present the immune system with a target that allows it to prepare its defenses should the actual virus ever invade.

In the case of Covid-19, most vaccines coach the immune system to target the spike protein of the SARS-CoV-2 virus, which it uses to start the infection process. This helps the immune system generate strong neutralizing antibodies. But the spike protein is one of the fastest mutating parts of the virus, making it a moving target.

The fact that B cells and T cells have managed to hold off newer variants hints that it may be possible to target the virus in other ways. Rather than just making neutralizing antibodies that attach to the spike, the adaptive immune system could also produce non-neutralizing antibodies that bind to other regions of the virus that mutate very little, if at all. While these antibodies may not block an infection from taking root, they may be able to provide more durable protection against severe illness that holds up against future SARS-CoV-2 variants.

Another approach is to present the immune system with a variety of different potential mutations of a virus, allowing white blood cells to prepare a response to a spectrum of threats and fill in the blanks.

Universal vaccines have not been deployed before, so researchers are in uncharted territory, and the shots likely wont be ready ahead of a potential fall spike in Covid-19 cases. But developing such a vaccine could eventually reduce the need for boosters and give health officials a head start on countering future outbreaks.

In the meantime, US health officials are planning to distribute vaccines reformulated to target newer Covid-19 variants by September, but its not clear yet what the optimal strategy will be to deploy them given the wide range of immune protection across the population. Between infections and vaccinations, the majority of people in the country have had some exposure to the virus, granting some degree of protection. And since the adaptive immune response to Covid-19 seems to be robust in most people, it may not be necessary for everyone to get an additional shot.

One option is to seek out those with weaker immune systems for boosters. Researchers have now developed a rapid test to measure T cell responses to Covid-19 that could identify people who are more vulnerable to reinfections or breakthrough infections.

Though vaccines are absorbing the most severe consequences from Covid-19, infections are still proving disruptive. Covid-19 outbreaks are contributing to staffing shortages at hospitals, schools, and airlines, leading to delays and cancellations. And the more the virus spreads, the more opportunities it has to mutate in dangerous ways. Stopping this threat requires limiting infections, which in turn still demands measures like social distancing and wearing face masks.

So as good as the next generation of vaccines may prove to be, they are only one element of a comprehensive public health strategy for containing a disease.

View original post here:

How long-term Covid-19 immunity paves the way for universal Covid-19 vaccines - Vox.com

Association of state COVID-19 vaccine mandates with staff vaccination coverage, staffing shortages in nursing homes  Newswise

The rest is here:

Association of state COVID-19 vaccine mandates with staff vaccination coverage, staffing shortages in nursing homes - Newswise

I would rather get COVID than get the Vaccine.

One week later I changed my mind.

My mother, my daughter, and I were driving back from Wyoming last August after two weeks of vacation fun. The highlight of the trip was a huge country and western concert featuring Blake Shelton. We shared the event with tens of thousands of his loyal fans, and even though COVID was still on the rampage, we werent worried the concert was outdoors.

It was during that trip that I was asked if I was vaccinated against COVID and answered with the statement I soon regretted. Its just that I was more scared of the Vaccine than I was of COVID. At the time I didnt know enough about either.

Soon into our return trip my daughter developed symptoms fatigue, fever, nausea. Three days later it hit me.

At first, we thought we both had food poisoning. By the third day of my illness, my husband insisted I test and, although testing positive, the symptoms werent bad, just some stomach issues, chills, fever, a cough. But on day five things really ramped up.

I had lots of pain all over, especially in my lungs. The fever got worse and I know this sounds strange, but I had psychological symptoms. I couldnt swallow or drink. I would put water in my mouth but couldnt swallow, like my throat was blocked, I became very thirsty and got dehydrated quickly. By day ten I was hospitalized.

During my five-day hospitalization I responded quickly to treatment and was able to eat and drink on my own. A health care provider told me I was experiencing PTSD labeled COVID Psychosis. And for good reason.

I came home on oxygen, extremely weak, fatigued and feeling incredible pain. I couldnt stand on my own, and my husband whom I incidentally infected with COVID, literally had to take care of my most basic needs while sick with the virus himself. Fortunately for both of us his symptoms, though similar to mine initially, were not severe.

During my recovery I had a lot of nerve pain, especially in my legs. I was so weak when I got home from the hospital, I couldnt coordinate my legs for weeks. Using stairs was beyond my ability. My doctor advised me not to sleep all day long, and it took all my husband and I could do to achieve that even marginally. I had no bladder control, lost hair by the handfuls, and experienced cognitive and memory changes.

Now, almost one year later, COVID still has its grip on me and its impact may be with me for life.

It took six months before I could even begin to feel normal. Going out in public was initially terrifying, but I gradually became less nervous. I often lose words in everyday conversation, and the writing that used to come easily to me does not. Because my lung capacity is restricted, the long weekend hikes with the family remain on hold; I am just not physically up to it. To say getting COVID was a game changer is putting it mildly.

Before all this happened, I never got sick. I am a younger adult, and according to the statistics I should have been fine. I believed I was not at risk because of my age and because I didnt have any underlying conditions. It seemed those people I knew who resisted getting the Vax already had COVID and were fine. It just didnt seem to be a threat.

But the effects of COVID went beyond me. My young daughter was scared, and as the infection lingered, was disappointed that her mom missed several events that were important to us.

How my husband was able to take care of me and our daughter and his own infection is truly amazing I could not have gotten through without his tireless support.

Yet, in spite of my horrific experience with COVID and the continuing challenges I face on a daily basis, I have friends and family who are still hesitant to get the vaccine. I want them to understand how close I felt to not making it, that being a Vax nonbeliever doesnt prevent the virus from infecting you. Just because you had COVID doesnt mean you wont get it again. And again. And the immunity that comes from having COVID is short-lived.

It almost cost me my life, but it may have helped me save others, as several members of my immediate and extended family have taken the shot, and yes, myself included.

During my first post COVID grocery store stop, an irate woman saw my mask and snapped You are the Problem!

I prefer to think of myself as the solution.

Lora Powell as told to Chris Smith of Muncy who was a prevention education/highway safety specialist for over 35 years and is a member of Lets End COVID!, a group of people in Northcentral PA working to overcome the COVID-19 pandemic through education, outreach and mitigation.

Today's breaking news and more in your inbox

See the article here:

A week that changed one woman's mind about the COVID-19 vaccine - Williamsport Sun-Gazette

Programs in countries around the world have begun quietly compensating people who have been injured by or died as a result of the COVID-19 vaccines.

Humans are biologically diverse, with respect to both genetic makeup and past environmental exposures. Because of this, explained neurologist Dr. Robert Lowry, people can react very differently to the same medication or vaccination. Whenever a new drug or biologic hits the market, some people will have bad reactions and others may even suffer serious adverse events as a result.

Even under the best testing conditions, rare reactions will be missed. This is especially true for any product which is fast-tracked or authorized for emergency use before all the phases of necessary testing are complete.

COVID-19 vaccines are no exception. Despite the fact that we are constantly and consistently assured that COVID-19 vaccines are safe, and that severe adverse reactions are very rare, the FDA and the CDC with its Advisory Committee on Immunization Practices, as well as the scientists and executives at each of the participating drug companies, know that some people will become permanently disabled or even die as a result of vaccination.

In fact, in 2011 the Supreme Court of the United States (pdf) reiterated the idea that vaccines, like other pharmaceutical products, are unavoidably unsafe.

In many countries around the world, consumers who are injured as a result of vaccines are covered by government compensation programs. In the United States there are two government-funded programs that are designed to compensate consumers for injuries, at the same time shielding vaccine manufacturers from liability for any serious injuries their products cause: The National Vaccine Injury Compensation Program (VICP) and the Countermeasures Injury Compensation Program (CICP).

As of July 1, 2022, not a single claim has been compensated by the CICP. However, 31 COVID-19 countermeasure claims have been denied, because the standard of proof for causation was not met and/or a covered injury was not sustained, according to the CICP website. One COVID-19 countermeasure claim, a COVID-19 vaccine claim due to an anaphylactic reaction, has been determined eligible for compensation and is pending a review of eligible expenses.

At the same time, countries around the world are quietly compensating families whose loved ones have been injured or have died as a result of COVID-19 vaccines.

The Japan Times reported this week that a 91-year-old woman who died after suffering an allergic response and sudden heart attack is the first person in Japan to be compensated for a COVID vaccine injury.

A ministry of health panel ruled that a causal relationship could not be denied in her case. Her family will receive a lump sum worth approximately $325,000.

The panel reviewed another 11 cases ranging in age from 20s to 90s but did not reach any other ruling.

So far in Japan, according to the article, 3,680 people have applied for compensation, 820 have been approved and 62 denied, with decisions on another 16 being postponed.

On June 24, 2022, Taiwans National Vaccine Injury Compensation Program held a meeting to review 65 cases, according to the Taipei Times. The Taiwanese program awarded compensation to 10 claimants. These awards included a lump sum worth $116,877 to the family of someone who died after receiving the AstraZeneca vaccine.

This patient was hospitalized 10 days after receiving the vaccine due to a headache and vomiting. Testing revealed thrombocytopenia, a sometimes-lethal blood disorder that is characterized by low platelets.

However, the patient was discharged the next day, only to return that evening after losing consciousness. The patient died of intracerebral hemorrhage, a common cause of stroke.

When the vaccination program first rolled out in the United States, in December of 2020, an otherwise healthy obstetrician-gynecologist, Dr. Gregory Michael, 56, of Miami Beach, Florida, also died of thrombocytopenia.

Although his death occurred approximately two weeks after he got Pfizers COVID-19 vaccine, and prompted an article exploring this side effect in the New York Times, the coroner deemed that there was no medical certainty that the complications from immune thrombocytopenia was vaccine-induced.

Vicki Spit was the first of a handful of people in the United Kingdom to be awarded compensation for injuries due to COVID vaccines, according to a June 24, 2022 article in the British Medical Journal.

Spits 48-year-old partner, Zion, became ill eight days after receiving the AstraZeneca vaccine and died. The victims were awarded the maximum: $150,000. As of May 2022, 1,681 claims for vaccine injury following COVID-19 vaccinations had been filed.

As quoted in the BMJ, Sarah Moore, a spokeswoman for the law firm representing the victims or their families, pointed out that though the awards will not do much to alleviate the financial hardships caused by the injuries, they constitute the clearest statement yet, by the government, that in some rare instances the COVID-19 vaccines have caused very significant injury or death.

Moore believes most of the compensation awards were for vaccine-induced thrombotic thrombocytopenia (VITT) or cerebral venous sinus thrombosis.

At the same time, Yahoo News has reported that 444 cases of VITT have been recorded in the United Kingdom from 49 million doses of the vaccine, with 81 deaths.

According to Canadas Vaccine Injury Support Program (VISP), from June 1, 2021 to June 1, 2022, 774 claims have been received. Eight of these claims were approved by the Medical Review Board, meaning these claims represent cases where it has been determined by the Medical Review Board that there is a probable link between the injury and the vaccine and that the injury is serious and permanent.

According to the VISP website, eligible individuals may receive income replacement indemnities; injury indemnities; death benefits; coverage for funeral expenses; reimbursement of eligible costs such as otherwise uncovered medical expenses.

Thrombocytopenia can lead to blood clots as well as hemorrhaging. Thrombosis is another word for blood clots. Since it is very unusual for an otherwise healthy younger person to suffer from blood clots, the connection between the vaccines and this injury are difficult to refute.

Scandinavian countries have paid more attention to COVID-19 vaccine injuries than other countries. Norway compensated its first three victims in July of last year, a woman in her 40s who died, as well as a man and a woman in their 30s who both survived their vaccine injuries.

All three were healthcare workers who received the AstraZeneca vaccine, which Norway stopped administering on March 11, 2021, due to reports of serious blood clots, low platelet counts, and abnormal bleeding.

In fact, Norwegian doctors were among the first to point out the connection between the vaccine and these injuries.

Denmark, too, has been quickly and quietly processing vaccine injury claims. The Danish government awarded compensation for their first case of VITT in May of 2021.

At the time, 158 people had filed claims for COVID-19 vaccine injuries. The director of the patient compensation board, Karen Inger-Bast, said, Generally, we often see injuries from vaccination. We also see them from, for example, vaccination against influenza and childrens diseases. Thats also how it will be with COVID-19, with up to 5 million people being vaccinated.

Yet, while other countries are compensating people who have been injured by COVID-19 vaccines, America has yet to financially assist a single claimant. According to the Health Resources and Service Administration, as of July 1, 2022, the CICP had yet to award compensation to anyone for damages due to a COVID-19 vaccine.

Thirty-one claims have been denied compensation because the standard of proof for causation was not met and/or a covered injury was not sustained.

A single claim on behalf of someone who suffered an immediate anaphylactic reaction has been deemed eligible for compensation but is pending a review of eligible expenses. For the majority of claims, the CICP is still waiting for records and documentation to be submitted, the website claims.

The AstraZeneca vaccine associated with so many of the injuries quietly compensated has not been made available in the United States.

At the same time, as of July 22, 2022, 86,604 serious adverse events from COVID-19 vaccines administered in the United States have been reported to the Vaccine Adverse Event Reporting System (VAERS), including 13,805 deaths.

Its difficult to determine exactly how many of those involve blood clots, abnormal bleeding, or low platelets because each of those conditions can be coded in many different ways, but a search by The Epoch Times retrieved 2,609 cases that included some mention of thrombosis or thrombocytopenia, including 420 deaths.

These conditions account for only a small portion of the adverse events that have been reported to the CDC and the FDA. In order for people who have suffered from these adverse events to make a claim, a temporal association between the vaccine and the injury or some kind of causation must be established, as the Norwegian doctors and others did for VITT.

In the United States, we may wait a long time for science that establishes causation with respect to vaccine injuries.

In 2011, the Institute of Medicine conducted a detailed investigation into the science available on 158 suspected links between vaccines and specific adverse outcomes. In this report, the IOM ruled that the science was not sufficient to determine whether a causal link existed or not for 135 of the vaccine injuries patients had sustained.

A 2014 Associated Press investigation found that many families with medically documented non-COVID vaccine injuries have been waiting for yearssome over a decadefor the government to help them.

For now, while other countries are quietly making amends, American families who have lost loved ones and Americans who have seen sharp declines in their health following COVID-19 vaccination have nowhere to turn.

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times. Epoch Health welcomes professional discussion and friendly debate. To submit an opinion piece, please follow these guidelines and submit through our form here.

See original here:

COVID Vaccine Injuries Quietly Being Compensated Around the World, Are You Eligible? - The Epoch Times

Pediatrician on COVID-19 vaccines and back-to-school

Updated: 5:29 PM EDT Jul 28, 2022

Hide TranscriptShow Transcript

>> BELIEVE IT OR NOT THE START OF THE SCHOOL YEAR WILL BE HERE BEFORE WE KNOW IT. AND A NEW ANALYSIS SHOWS MANY KIDS ARE STILL NOT PROTECTED AGAINST COVID 19. >> HERE TO ANSWER YOUR QUESTIONS IS DR. KRISTIN MOFFITT, AN INFECTIOUS DISEASES EXPERT AT BOSTON CHILDRENS HOSPITAL. DR. MOFFITT, THANKS FOR BEING HERE. CNN LOOKED AT THE DATA AND FOUND THAT LESS THAN HALF OF CHILDREN AND TEENS ARE FULLY VACCINATED NATIONWIDE AND ONLY A TENTH HAVE BEEN BOOSTED. EVEN WHERE STATES LIKE MASSACHUSETTS 80% GENERALLY HAVE IT BUT NOT AND THAT AGE BRACKET. DOES THIS SURPRISE YOU? >> ITS NOT SURPRISING THAT THE VACCINE UPTAKE RATES ARE HIGHER THAN HIGH SCHOOL -- HIGHER IN HIGH SCHOOL THEN MIDDLE SCHOOL AND ELEMENTARY SCHOOL. MUCH OF THIS IS DUE TO THE PERCEPTION THAT IF YOU HAVE BEEN INFECTED BY COVID AND YOU HAVE HAD THE PRIMARY VACCINES, THAT YOU DONT NEED A BOOSTER. WE KNOW THAT BOOSTERS ARE SAFE AND THOSE WHO HAVE BEEN INFECTED AND THEY ENHANCE OUR PROTECTION. THEY WILL DO EVEN MORE TO PROTECT US AGAINST SEVERE INFECTION, SO KIDS SHOULD GET BOOSTED IF THEY ARE ELIGIBLE. >> MASSACHUSETTS HAS CONSISTENTLY HAD A HIGHER VACCINATION RATE OVERALL. BUT, ANECDOTALLY, WE UNDERSTAND THERE HASNT BEEN HUGE DEMAND FOR VACCINATIONS FOR THE YOUNGEST KIDS. IS THAT WHAT YOURE SEEING? >> UNFORTUNATELY, YES. MASSACHUSETTS IS ONLY VACCINATED 10% OF CHILDREN UNDER THE AGE OF FIVE. THAT PUTS MASSACHUSETTS IN THE THIRD HIGHEST RANK FOR VACCINATION RATES IN THIS AGE ONLY BEHIND THE DISTRICT OF COLUMBIA AND VERMONT BUT THAT IS A LOW PERCENTAGE ESPECIALLY FOR THESE VACCINES HAVING BEEN AVAILABLE FOR 90 DAYS NOW. >> IF PARENTS ARE STILL ON THE FENCE ABOUT GETTING YOUNG KIDS THAT FIRST DOSE, WHAT DO YOU WANT THEM TO KNOW? >> I WOULD WANT PARENTS TO KNOW THAT WE KNOW THAT THESE VACCINES WILL HELP ATTACKED YOUNG CHILDREN AGAINST SEVERE INFECTION AND HOSPITALIZATION FROM COVID-19. WHILE ITS TRUE THAT PEDIATRIC HOSPITALIZATIONS ARE LESS LIKELY THAN FOR ADULTS, BUT THEY DO HAPPEN. THE RATES HAVE BEEN RISING BECAUSE OF SO MUCH TRANSMISSION RIGHT NOW. PEDIATRIC RATES FOR HOSPITALIZATION ARE HIGHER FOR KIDS UNDER FIVE AND KIDS OF OTHER AGES AND WE KNOW THIS CAN BE PREVENTED BY VACCINATION. >> FROM YOUR PERSPECTIVE, WHATS THE BEST PLAN OF ATTACK RIGHT NOW FOR GIVING KIDS THE BEST PROTECTION ONCE SCHOOL STARTS? >> FOR KIDS WHO HAVE NOT STARTED OR COMPLETED THE PRIMARY SERIES, GET IT STARTED, GET IT COMPLETED . IF YOUR CHILD IS OLD ENOUGH TO BE ELIGIBLE FOR A BOOSTER, GET THE BOOSTER. BEING IS IMMUNIZED AS POSSIBLE IS STILL VERY EFFECTIVE AT PREVENTING SEVERE INFECTION REGARDLESS OF THE VARIANT CIRCULATING. WE DONT KNOW WHERE WERE GOING TO BE IN ONE MONTH WHEN THE SCHOOL DOORS OPEN. >> DR. MOFFITT, THANK YOU. AND TO OUR VIEWERS IF YOU HAVE YOUD LIKE OUR EXPERTS TO ANSWER EMAIL THEM TO ASK AT WCVB.CO

Pediatrician on COVID-19 vaccines and back-to-school

Updated: 5:29 PM EDT Jul 28, 2022

Kristin Moffitt, an infectious disease specialist with Boston Children's Hospital, talks about COVID-19 vaccines as kids prepare to go back to school.

Kristin Moffitt, an infectious disease specialist with Boston Children's Hospital, talks about COVID-19 vaccines as kids prepare to go back to school.

Go here to see the original:

Pediatrician on COVID-19 vaccines and back-to-school - WCVB Boston

1. Young childrens Covid-19 vaccinations lag behind other age groups  vtdigger.org
2. KFF COVID-19 Vaccine Monitor: July 2022  Kaiser Family Foundation
3. Study continues on COVID-19 as does state's coercive vaccine mandate on state employees  Washington Policy
4. State health officials urge parents to get kids vaccinated for COVID-19 before school starts  WNEM
5. More than 40% of parents of young kids say they will not get their child a Covid-19 vaccine, survey finds  CNN
6. View Full Coverage on Google News

See the article here:

Young childrens Covid-19 vaccinations lag behind other age groups - vtdigger.org